Research

Wellstand Health experts Dr. Anthony Napolitano, CEO and Paul Tindall, CTO recently attended the Becker’s Healthcare event in Chicago on how to address foundational aspects of digital transformation, telehealth, clinician burnout, the revenue cycle, cybersecurity, and artificial intelligence. The theme of the conference: “Healthcare is changing. Don’t get left behind. ”

Since March 2020, the Food and Drug Administration (FDA) has granted Emergency Use Authorizations (EUAs) for dozens of Real-Time Polymerase Chain Reaction (RT-PCR) diagnostic tests to identify patients infected with SARS-CoV-2, the novel SARS coronavirus strain of 2019 (COVID-19).

In previous posts, we’ve covered the importance of COVID-19 testing for helping to contain the impact of both new disease variants and breakthrough cases for vaccinated individuals. With the global rise of variant B.1.617.2, otherwise known as the delta variant variant, these concerns are becoming very real indeed. While it’s not time for panic, this is the perfect time to get informed about the delta variant and the risks it poses.